- Home
- ADRX vs ASTH Comparison
ADRX vs ASTH Comparison
Compare ADRX & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADRX | ASTH |
|---|---|---|
| Founded | 2019 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2026 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ADRX | ASTH |
|---|---|---|
| Price | $14.58 | $31.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $34.25 | ★ $51.89 |
| AVG Volume (30 Days) | ★ 396.7K | 319.0K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $519,907,752.00 |
| Revenue This Year | $89.41 | $24.88 |
| Revenue Next Year | $510.33 | $10.06 |
| P/E Ratio | ★ N/A | $33.44 |
| Revenue Growth | N/A | ★ 45.90 |
| 52 Week Low | $12.50 | $18.08 |
| 52 Week High | $19.57 | $51.60 |
Technical Indicators
Market Signals| Indicator | ADRX | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 33.33 |
| Support Level | $12.50 | $23.00 |
| Resistance Level | $18.94 | $40.18 |
| Average True Range (ATR) | 1.59 | 2.09 |
| MACD | -0.16 | -0.66 |
| Stochastic Oscillator | 30.24 | 6.10 |
Price Performance
Historical ComparisonAbout ADRX ADARx Pharmaceuticals Inc. Common Stock
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
About ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.